Global Positive Airway Pressure Devices Market, By Product Type (Automatic Positive Airway Pressure, By Application By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032

Report Overview

In 2022, the Global Positive Airway Pressure Devices Market was worth US$ 3.0 billion. It is estimated to grow a CAGR of 6.0% between 2023-2032. It is expected to be worth US$ 5.3 billion

Positive Airway Pressure (PAP) devices are medical devices used to treat sleep-related breathing disorders such as obstructive sleep apnea (OSA). They deliver pressurized air to the airway, keeping it open during sleep and preventing episodes of apnea (temporary cessation of breathing). PAP therapy is effective in reducing or eliminating snoring, which is a common symptom of sleep apnea.

The pressurized air helps to keep the airway open and prevent the vibrations in the throat that cause snoring. This can lead to quieter and more restful sleep for the individual using the device and their sleeping partner. PAP therapy can alleviate daytime symptoms associated with sleep apnea, such as excessive daytime sleepiness, fatigue, morning headaches, and poor concentration.

By ensuring a consistent and uninterrupted supply of oxygen during sleep, PAP devices help to restore normal sleep patterns and promote restful sleep, resulting in increased daytime alertness and improved overall quality of life. The market’s primary drivers are the increasing global geriatric population and the rising prevalence of sleep and respiratory disorders. Additionally, a rise in patient compliance rate for PAP devices, new strategic initiatives, and key product innovations are expected to fuel the positive airway pressure devices market growth during the projection period.

Driving Factors

Rising incidence of sleep disorders

Sleep disorders are becoming more common across many parts of the globe. Which has directly affected the growth of the positive airway pressure devices market.

Positive airway pressure devices play a crucial role in treating sleep disorders, particularly obstructive sleep apnea (OSA). These devices are considered the gold standard for managing OSA and are also used in other sleep-related breathing disorders.

PAP therapy helps to maintain open and unobstructed airways during sleep, ensuring continuous and adequate airflow to the lungs. Thus, the rise in incidences of sleep disorders is anticipated to stimulate the demand for positive airway pressure devices during the projection period. This is a major factor driving the growth of the market.

Increasing prevalence of respiratory disorders

Several people around the globe suffer from different types of respiratory disorders. According to the Global Initiative for Chronic Obstructive Lung Disease, COPD affects an estimated 200 million individuals globally. It is the third biggest cause of death, with an annual death rate of roughly 3.2 million.

One of the most prevalent non-communicable diseases in the world, asthma affects 262 million people. The NCBI article from March 2022 estimates that the combined prevalence of COPD in South Asian nations in 2021 was 11.1%. The survey also noted that Bangladesh (13.5%) and North India (19.4%) had the highest COPD prevalence rates. Positive airway pressure devices can be beneficial for individuals with COPD, especially during acute exacerbations or episodes of respiratory distress. Bi-level Positive Airway Pressure (BiPAP) machines are often used.

BiPAP provides different pressure levels for inhalation and exhalation, making it easier for individuals with COPD to breathe out against resistance and facilitating better gas exchange. It can help relieve symptoms, improve oxygenation, and reduce the work of breathing during exacerbations. Therefore, the increasing prevalence of respiratory disorders is expected to boost demand for positive airway pressure devices market during the forecast period.

Restraining Factors

Side-effects associated with the use of PAP devices

Prolonged and continuous use of PAP devices can sometimes lead to skin irritation, redness, and pressure sores in areas where the mask makes contact with the skin. This is particularly true if the mask is too tight or if the individual has sensitive skin. Proper mask fit, regular cleaning, and using cushioning or protective products can help minimize these issues.

PAP therapy can cause dryness of the nasal passages, mouth, and throat due to the constant airflow. This can result in symptoms such as dry mouth, sore throat, nasal congestion, and nosebleeds. Humidifiers integrated with PAP devices or standalone humidifiers can be used to alleviate these symptoms and provide moisture. Thus, side effects associated with the use of PAP devices may limit the positive airway pressure devices market growth during the projected time period.

High cost of positive airway pressure devices

One significant disadvantage of PAP devices is their high cost. The cost factors associated with PAP therapy include the initial purchase of the device, ongoing maintenance, and replacement parts. PAP machines, whether it’s a Continuous Positive Airway Pressure (CPAP), Bi-level Positive Airway Pressure (BiPAP), or Auto-adjusting Positive Airway Pressure (APAP) device, can have a considerable upfront cost.

The price of these devices can vary based on the brand, model, features, and additional accessories included. The initial investment can be a financial barrier for some individuals, especially if they do not have insurance coverage or if their insurance has high deductibles or co-payments. Along with the PAP machine, there are additional supplies and accessories that need to be regularly replaced to maintain effective therapy. These include masks, headgear, filters, tubing, and humidifier chambers. These ongoing expenses can add up over time and contribute to the overall cost of PAP therapy. Thus, high cost PAP devices is expected to have a negative impact on the growth of the positive airway pressure devices market over the forecast period.

COVID-19 Impact Analysis

The pandemic disrupted global supply chains, affecting the manufacturing and distribution of positive airway pressure devices market. Lockdowns, travel restrictions, and social distancing measures imposed by various countries impacted the production, transportation, and availability of components and finished products. This led to delays in manufacturing, shortages, and challenges in meeting the increased demand.

However, the COVID-19 pandemic heightened the awareness of respiratory health and the importance of adequate ventilation. As a result, there has been an increased demand for PAP devices, particularly for treating sleep-related breathing disorders like obstructive sleep apnea (OSA). Individuals previously undiagnosed or untreated may have sought medical attention, leading to a surge in demand for PAP devices.

By Product Type Analysis

Continuous positive airway pressure (CPAP) devices are witnessing the highest growth.

The continuous positive airway pressure (CPAP) devices segment dominated the positive airway pressure devices market in 2022 with the largest revenue share of 65%. The demand for CPAP devices has been consistently high due to their effectiveness in treating sleep-related breathing disorders, especially obstructive sleep apnea (OSA). Sleep apnea is a common sleep disorder affecting a significant portion of the population worldwide. As awareness about sleep apnea increases, more individuals seek diagnosis and treatment, leading to a higher demand for CPAP devices. Thus, the growing prevalence of sleep apnea is a major factor stimulating the segment’s growth during the projection period.

Bi-level positive airway pressure (BiPAP) devices are anticipated to witness the fastest growth during the estimated period. BiPAP therapy is frequently used to manage COPD, a progressive respiratory disease. BiPAP devices can help individuals with COPD by providing different pressure levels during inhalation and exhalation, reducing the work of breathing and improving gas exchange. The demand for BiPAP devices has risen as more individuals with COPD recognize the benefits of this therapy in managing their symptoms and improving their quality of life. Therefore, the rising prevalence of COPD will fuel the demand for positive airway pressure devices market over the forecast period.

By Application Analysis

Obstructive sleep apnea application shows the highest growth.

The obstructive sleep apnea segment led the application segment with a revenue share of 62% in 2022. The high demand for positive airway pressure devices market, particularly CPAP machines, in treating obstructive sleep apnea can be attributed to the prevalence of OSA, the proven efficacy of PAP therapy, the associated health benefits, increased awareness, technological advancements, and the adoption of telemedicine and remote monitoring.

Moreover, the respiratory failure segment will multiply during the projection period. The growing demand for PAP devices in the management of respiratory failures can be attributed to the effectiveness of non-invasive ventilation, the benefits in specific respiratory conditions, advancements in technology, and the focus on home-based care and chronic disease management. These devices provide respiratory support and improve outcomes in various respiratory failure scenarios. This is a key factor stimulating the segment growth during the projected period.

By End-User Analysis

Hospitals and sleep labs are leading end-users

Hospitals & sleep labs are expected to dominate the positive airway pressure devices market with a revenue share of 55% throughout the forecasted time. The high demand for different PAP devices in hospitals and sleep labs stems from their crucial role in diagnosing, treating, and managing sleep-related breathing disorders. These devices are utilized for diagnostic sleep studies, titration studies, respiratory support, inpatient sleep studies, and patient education. Their effectiveness in improving sleep quality, alleviating symptoms, and preventing complications drive the demand for PAP devices in these settings.

Also, the home care segment is anticipated to witness high growth during the projection period. The aging population and the increasing prevalence of chronic respiratory conditions contribute to the demand for PAP devices in home care. Many individuals with conditions such as OSA, COPD, and neuromuscular disorders require long-term management and respiratory support.

Home care with PAP devices enables individuals to manage their conditions effectively while remaining in their familiar and comfortable environment. Thus, the rising geriatric population and the increasing prevalence of OSA, COPD, and neuromuscular disorders are major factors likely to fuel the segment growth during the projection period. This eventually gave rise to positive airway pressure devices market.

Positive Airway Pressure Devices Key Market Segments

Product Type

• Automatic Positive Airway Pressure (APAP) Devices
• Continuous Positive Airway Pressure (CPAP) Devices
• Bi-level Positive Airway Pressure (BiPAP) Devices

Application

• Obstructive Sleep Apnea
• Respiratory Failures
• COPD

End-User

• Hospitals and Sleep Labs
• Home Care
• Other end-users

Opportunity

Rising awareness regarding sleep disorders rising positive airway pressure devices market.

As awareness about sleep disorders, particularly obstructive sleep apnea (OSA), has grown, more individuals seek diagnosis and treatment. Sleep apnea awareness campaigns, education programs, and media coverage have highlighted the potential health risks of untreated sleep disorders. This increased awareness has led to a higher demand for PAP devices, the standard treatment for sleep-related breathing disorders.

If left untreated, sleep apnea can lead to various health complications, such as hypertension, cardiovascular diseases, diabetes, and cognitive impairments. Increased health awareness has emphasized diagnosing and treating sleep apnea to prevent these adverse health outcomes. Understanding the potential consequences of untreated sleep apnea has motivated individuals to seek PAP therapy and contributed to the demand for PAP devices. Thus, rising awareness regarding sleep disorders would promote the demand for positive airway pressure devices and provide new growth opportunities for the market in the upcoming period.

Trends

Advancements in technology

Positive airway pressure devices market is becoming increasingly connected and integrated with digital platforms. Many devices now offer Bluetooth or Wi-Fi connectivity, allowing patients and healthcare providers to monitor therapy data remotely. Patients can access usage statistics, track progress, and receive feedback through mobile applications or web portals. These smart features enable better patient engagement, therapy adherence, and remote monitoring.

Also, the integration of AI and machine learning algorithms is an emerging trend in PAP devices. These technologies have the potential to analyze large datasets, identify patterns, and provide personalized therapy recommendations. AI-driven algorithms can help automate mask fitting, optimize pressure settings, and predict patient responses to therapy, leading to more effective and efficient treatment. Thus, such key advancements in technology are likely to boost the growth of the positive airway pressure devices market in the upcoming time period.

Regional Analysis

North America leads the market by holding a major revenue share in the account.

The North American region is expected to hold the largest share of 50% in the positive airway pressure devices market during the projected time period. North America has a relatively high prevalence of sleep disorders, particularly obstructive sleep apnea (OSA). It is estimated that millions of individuals in North America are affected by OSA, and many remain undiagnosed.

As awareness about sleep disorders increases, more individuals are seeking diagnosis and treatment, leading to a higher demand for PAP devices. Also, the population in North America is aging, and sleep disorders, including OSA, become more common with age. As the older population grows, the demand for PAP devices increases due to the higher prevalence of sleep-related breathing disorders in this demographic. Therefore, the high prevalence of sleep disorders and the rising geriatric population are major factors driving the positive airway pressure devices market growth in the region during the forecasted time period.

Moreover, the Asia-Pacific region is likely to witness high growth during the estimated time period. Many countries in the Asia Pacific region have been investing in their healthcare infrastructure, including sleep medicine and respiratory care facilities.

The development of sleep clinics, specialized sleep centers, and respiratory care units has increased access to diagnosis and treatment for sleep-related breathing disorders. This has contributed to the growing demand for PAP devices as they are the primary treatment modality for conditions such as OSA. Thus, growing investments in healthcare infrastructure are likely to fuel the expansion of the positive airway pressure devices market throughout the region during the projection period.

Key Regions and Countries

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis

The global Positive Airway Pressure Devices market is moderately competitive, and major market players have a prominent presence. The market is growing at a high rate due to the growing incidence of sleep and respiratory disorders. Also, mergers and acquisitions, new strategic agreements, and key product innovations by key market players are expected to contribute to the market growth during the upcoming time period.

Top Key Players in Global Positive Airway Pressure Devices Market

• Fisher & Paykel Healthcare Ltd.
• Medtronic, Inc.
• Philips Respironics
• Curative Medical Inc.
• Armstrong Medical
• Lowenstein Medical UK Ltd
• ResMed
• Servona GmbH
• Medical Depot Inc
• Smith’s Group PLC
• Drive Devilbliss Healthcare Ltd.
• Other Key Players

Recent Developments

• In October 2021, Superior Sensor Technology, a U.S-based developer of advanced pressure sensors for industrial, HVAC, and medical applications, announced the release of a new dual low-pressure sensor product line for bi-level positive airway pressure (BiPAP), continuous positive airway pressure (CPAP), and automatic positive airway pressure (APAP) products used to treat sleep apnea and other breathing sleep disorders.
• In April 2021, Royal Philips, a health technology company, announced a new update regarding the recall notification for specific Philips mechanical ventilators, along with CPAP and BPAP devices, for addressing some crucial health risks specifically related to the PE-PUR, i.e., polyester-based polyurethane sound abatement foam component present in this equipment.

Report Scope